The efficacy of alpha-lipoic acid in improving oxidative, inflammatory, and mood status in women with episodic migraine in a randomised, double-blind, placebo-controlled clinical trial.
Mahnaz Rezaei KelishadiAmirmansour Alavi NaeiniGholamreza AskariFariborz KhorvashZahra HeidariPublished in: International journal of clinical practice (2021)
The results of this study suggest that ALA supplementation for 3 months has beneficial effects on improving the oxidative, inflammatory, and mood conditions of patients suffering from episodic migraine.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- phase ii
- study protocol
- phase iii
- end stage renal disease
- bipolar disorder
- open label
- oxidative stress
- ejection fraction
- newly diagnosed
- prognostic factors
- randomized controlled trial
- peritoneal dialysis
- chronic kidney disease
- sleep quality
- squamous cell carcinoma
- depressive symptoms